Piron recognized for driving surgical innovation and significant contributions to Canada’s healthcare industry
TORONTO, ON (SEPTEMBER 19, 2017) — Cameron Piron, president and co-founder of Synaptive Medical Inc., was recognized for his contributions to the Canadian healthcare industry at the 2017 Bloom Burton Award Gala, held on September 14 in Toronto.
Anthony Giovinazzo, former president and CEO of Cynapsus Therapeutics, was named the award’s inaugural winner for his role in the company’s development of a drug that treats OFF episodes in patients with Parkinson’s disease.
Dr. Allen Eaves, founder, president and CEO of STEMCELL Technologies, was also named a finalist to recognize his role in streamlining medical research process in Canada and around the world.
Here’s an excerpt from Piron’s remarks:
It’s a great honor to be nominated with two giants in the Canadian landscape. Anthony Giovinazzo is responsible for one of the largest exits in recent memory in Canada’s life sciences sector, while Dr. Allen Eaves is widely known for his substantive contributions to one of the most impactful scientific evolutions and clinical solution with applications to a wide range of health issues.
I accept the nomination on behalf of our entire founding team. Without their ongoing collaboration, combined with the hard work of our talented executive, engineering, manufacturing and commercial teams, we would not be the company we are today.
The opportunity to work on imaging, informatics, robotics and advanced surgical optics, and to see these systems work in synchrony in an operating theater is the most rewarding experience one can imagine. Working with the most talented engineers, business people, operators and clinicians on an urgent timeline to serve patients and those who care for them is simply a great honor and drives us to accomplish more.
Our experience demonstrates that Canada is an ideal country to which to operate and grow in the healthcare space. We’ve seen support for entrepreneurship drastically increase between when we founded Sentinelle Medical and now Synaptive. After incubating in the MaRS ecosystem graduating to offices in the Fashion District, we’re designing, manufacturing, servicing and installing solutions to help people around the world.
Our serial experiences, combined with those of our fellow nominees, demonstrate how Canadian firms and innovators are reaching critical mass and changing the way Canada’s healthcare industry.
I’d like to thank Bloom Burton for their recognition for all three nominees, and for their increasing leadership role in our field at this critically important juncture.
About Synaptive Medical | Synaptive Medical Inc., a Toronto-based medical device and technology company, collaborates with leading clinicians and healthcare systems to revolutionize products and services that cross traditional barriers to enable continuous improvement in care delivery in and beyond the operating room. Synaptive’s integrated BrightMatter™ solutions — including surgical planning, navigation and visualization, and an informatics platform — are designed to give clinicians the right information they need to ensure the best possible outcomes for patients.
About the Bloom Burton Award | Bestowed annually, the Bloom Burton Award honours an individual scientist, inventor, executive, entrepreneur, industry leader or policy maker who made the greatest impact in Canada’s innovative healthcare industry. Nominees are accepted from the biotechnology, pharmaceutical, medical device, diagnostic/imaging, research instrumentation, consumer health, healthcare services or healthcare IT sectors, and from all the therapeutic indications and stages of development. The winner is chosen by an external judging panel of international leaders in healthcare investment, entrepreneurship and journalism.